Cardiothoracic & vascular anesthesia

Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

Use of rFVIIa in HTx decreased over the past decade, whereas off-label PCC use increased. Receipt of rFVIIa was associated with thrombosis; however, patients who received rFVIIa were more severely ill, and risk adjustment may have been incomplete.

Study context

Population
Adults undergoing heart transplantation (HTx) in Virginia hospitals, 2012–2022
Participants
899 adults
Exposure
Off-label rFVIIa, on-label prothrombin complex concentrate (PCC) and off-label PCC use: trends over time and association with postoperative thrombosis
  • rFVIIan = 100
  • On-label PCCn = 69
  • Off-label PCCn = 80
Outcome
Use of procoagulant factor concentrates and trend over the 10-year period
Methodological detailsstatewide database, multivariate logistic regression
  • Statewide database
  • Multivariate logistic regression

Main finding

As reported in the abstract

Downward trend in rFVIIa use
P = 0.04
No trend in on-label PCC use
P = 0.12
Increase in off-label PCC use
P < 0.001

Observational data: associations, not effects.

Further findings

Transfusion and CPB time in rFVIIa recipients

Patients who received rFVIIa were transfused more and had longer CPB time
P < 0.001

Safety

Postoperative thrombosis

OR (95% CI)P value
rFVIIaMultivariate logistic regression1.92 (1.12–3.29)P = 0.02
On-label PCCMultivariate logistic regression0.98 (0.49–1.96)P = 0.96
Off-label PCCMultivariate logistic regression0.61 (0.29–1.30)P = 0.20

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia. J Cardiothorac Vasc Anesth. Published 4 October 2023. doi:10.1053/j.jvca.2023.10.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.